Shenyang Xingqi Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of ophthalmic drugs. Its products include nutrition and corneal repair drugs, ophthalmic anti-inflammatory and anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluid, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, and dry eye medicines. The company was founded on March 24, 1977 and is headquartered in Shenyang, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company